Symbols / CDT $4.20 +6.33% CDT Equity Inc.

Healthcare • Biotechnology • United States • NCM
CDT Chart
About

CDT Equity Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has strategic services agreement with formulation development CDMO Agility Life Sciences to develop new solid oral-dosage form products. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 19.83M
Enterprise Value -1.71M Income -20.30M Sales —
Book/sh 83.78 Cash/sh 58.89 Dividend Yield —
Payout 0.00% Employees 6 IPO —
P/E — Forward P/E — PEG —
P/S — P/B 0.05 P/C —
EV/EBITDA 0.10 EV/Sales — Quick Ratio 0.99
Current Ratio 1.66 Debt/Eq 43.83 LT Debt/Eq —
EPS (ttm) -397.65 EPS next Y — EPS Growth —
Revenue Growth — Earnings 2025-11-12 15:00 ROA -206.95%
ROE — ROIC — Gross Margin 0.00%
Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 4.72M
Shs Float 57.96K Short Float 3.71% Short Ratio 0.18
Short Interest — 52W High 4200.00 52W Low 3.64
Beta 2.08 Avg Volume 65.75K Volume 37.05K
Target Price — Recom None Prev Close $3.95
Price $4.20 Change 6.33%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$4.26
Latest analyst target
3. DCF / Fair value
$-63.05
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$4.26
Low
—
High
—
Mean
—
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-19 FARLEY CHELE CHIAVACCI Director — 10,553 $1.04 $10,975
2025-12-08 REGAN ANDREW J. Chief Executive Officer — 224,800 $1.79 $402,392
2025-09-19 BLIGH JAMES Chief Financial Officer — 480,000 — —
2025-09-19 REGAN ANDREW J. Chief Executive Officer — 1,120,000 $0.69 $768,656
2025-08-12 LEWIS-HALL FREDA C Director — 35,000 — —
2025-08-12 FARLEY CHELE CHIAVACCI Director — 35,000 — —
2025-08-12 FRY SIMON JEREMY Director — 35,000 — —
2025-06-03 REGAN ANDREW J. Chief Executive Officer — 154,799 $3.23 $500,001
2025-04-16 CHARLES FAITH L. Director — 115,194 $0.87 $100,000
2025-03-28 LEWIS-HALL FREDA C Director — 47,612 $0.89 $42,375
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
15.12
+187.32%
5.26
+66.52%
3.16
-0.41%
3.17
Research And Development
3.38
+3653.33%
0.09
-18.92%
0.11
-60.78%
0.28
Selling General And Administration
12.04
+132.81%
5.17
+69.63%
3.05
+5.50%
2.89
General And Administrative Expense
12.04
+132.81%
5.17
+69.63%
3.05
+5.50%
2.89
Other Gand A
12.04
+132.81%
5.17
+69.63%
3.05
+5.50%
2.89
Total Expenses
15.12
+187.32%
5.26
+66.52%
3.16
-0.41%
3.17
Operating Income
-15.12
-187.32%
-5.26
-66.52%
-3.16
+0.41%
-3.17
Total Operating Income As Reported
-15.42
-193.03%
-5.26
-66.52%
-3.16
+0.41%
-3.17
EBITDA
-15.85
-619.13%
3.05
+162.47%
-4.89
-54.02%
-3.17
Normalized EBITDA
-15.35
-298.99%
-3.85
-12.32%
-3.42
-24.00%
-2.76
Reconciled Depreciation
0.46
0.00
—
—
EBIT
-16.31
-634.10%
3.05
+162.47%
-4.89
-54.02%
-3.17
Total Unusual Items
-0.50
-107.25%
6.90
+571.96%
-1.46
-255.72%
-0.41
Total Unusual Items Excluding Goodwill
-0.50
-107.25%
6.90
+571.96%
-1.46
-255.72%
-0.41
Net Income
-17.80
-3227.48%
-0.54
+89.05%
-4.89
-33.63%
-3.66
Pretax Income
-17.81
-726.74%
2.84
+158.15%
-4.89
-33.63%
-3.66
Net Non Operating Interest Income Expense
-1.49
-661.73%
-0.20
0.00
—
Interest Expense Non Operating
1.51
+613.74%
0.21
0.00
—
Net Interest Income
-1.49
-661.73%
-0.20
0.00
—
Interest Expense
1.51
+613.74%
0.21
0.00
—
Interest Income Non Operating
0.01
-13.33%
0.01
0.00
—
Interest Income
0.01
-13.33%
0.01
0.00
—
Other Income Expense
-1.20
-114.46%
8.30
+580.60%
-1.73
-256.82%
-0.48
Other Non Operating Income Expenses
-0.70
-150.00%
1.40
+628.30%
-0.27
-263.01%
-0.07
Gain On Sale Of Security
-0.50
-107.25%
6.90
+571.96%
-1.46
-255.72%
-0.41
Tax Rate For Calcs
0.00
-100.00%
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
-100.00%
1.45
0.00
0.00
Net Income Including Noncontrolling Interests
-17.81
-726.74%
2.84
+158.15%
-4.89
-33.63%
-3.66
Net Income From Continuing Operation Net Minority Interest
-17.80
-3227.48%
-0.54
+89.05%
-4.89
-33.63%
-3.66
Net Income From Continuing And Discontinued Operation
-17.80
-3227.48%
-0.54
+89.05%
-4.89
-33.63%
-3.66
Net Income Continuous Operations
-17.81
-726.74%
2.84
+158.15%
-4.89
-33.63%
-3.66
Normalized Income
-17.30
-189.04%
-5.99
-74.77%
-3.42
-5.51%
-3.25
Net Income Common Stockholders
-17.80
-3227.48%
-0.54
+89.05%
-4.89
-33.63%
-3.66
Diluted EPS
-38,616.05
-56.86%
-24,617.89
-21.40%
-20,278.01
-33.63%
-15,174.27
Basic EPS
-38,616.05
-1675.62%
-2,174.80
+89.28%
-20,278.01
-33.63%
-15,174.27
Basic Average Shares
0.00
+87.40%
0.00
+2.07%
0.00
+0.00%
0.00
Diluted Average Shares
0.00
+87.40%
0.00
+2.07%
0.00
+0.00%
0.00
Diluted NI Availto Com Stockholders
-17.80
-193.96%
-6.06
-23.92%
-4.89
-33.63%
-3.66
Average Dilution Earnings
0.00
+100.00%
-5.52
—
—
Other Taxes
-0.30
—
—
—
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Assets
4.19
-41.96%
7.22
+144380.00%
0.01
0.00
Current Assets
2.71
-52.64%
5.73
0.00
—
Cash Cash Equivalents And Short Term Investments
0.55
-86.90%
4.23
0.00
—
Cash And Cash Equivalents
0.55
-86.90%
4.23
0.00
—
Receivables
0.49
0.00
—
—
Other Receivables
0.49
—
—
—
Prepaid Assets
1.67
+11.10%
1.50
0.00
—
Total Non Current Assets
1.48
-0.87%
1.49
+29720.00%
0.01
0.00
Net PPE
0.30
0.00
—
—
Gross PPE
0.30
0.00
—
—
Other Properties
0.30
—
—
—
Goodwill And Other Intangible Assets
—
0.00
-100.00%
0.01
0.00
Other Intangible Assets
—
—
0.01
—
Other Non Current Assets
1.18
-21.19%
1.49
—
—
Total Liabilities Net Minority Interest
10.99
+43.03%
7.68
-23.91%
10.09
+69.88%
5.94
Current Liabilities
10.74
+496.39%
1.80
-56.87%
4.18
+86.85%
2.23
Payables And Accrued Expenses
3.39
+315.56%
0.82
-68.42%
2.58
+15.93%
2.23
Payables
1.43
+564.19%
0.21
—
—
Accounts Payable
1.43
+564.19%
0.21
0.00
—
Current Accrued Expenses
1.96
+226.62%
0.60
-76.74%
2.58
+15.93%
2.23
Current Debt And Capital Lease Obligation
7.35
+646.19%
0.98
+462.86%
0.17
—
Current Debt
7.23
+634.11%
0.98
+462.86%
0.17
—
Other Current Borrowings
6.66
+732.00%
0.80
+357.14%
0.17
—
Current Capital Lease Obligation
0.12
0.00
—
—
Other Current Liabilities
—
—
1.42
+23516.67%
0.01
Total Non Current Liabilities Net Minority Interest
0.24
-95.83%
5.88
-0.64%
5.92
+59.64%
3.71
Long Term Debt And Capital Lease Obligation
0.11
0.00
-100.00%
1.83
+144.99%
0.75
Long Term Debt
—
—
1.83
+144.99%
0.75
Long Term Capital Lease Obligation
0.11
0.00
—
—
Tradeand Other Payables Non Current
0.00
-100.00%
5.74
0.00
—
Non Current Deferred Liabilities
—
0.00
-100.00%
4.08
+38.03%
2.96
Non Current Deferred Revenue
—
0.00
-100.00%
4.08
+38.03%
2.96
Stockholders Equity
-6.79
-1386.43%
-0.46
+95.47%
-10.09
-69.79%
-5.94
Common Stock Equity
-6.79
-1386.43%
-0.46
+95.47%
-10.09
-69.79%
-5.94
Capital Stock
0.01
+100.00%
0.01
+16.67%
0.01
0.00
Common Stock
0.01
+100.00%
0.01
+16.67%
0.01
0.00
Preferred Stock
0.00
0.00
0.00
—
Share Issued
0.00
+87.40%
0.00
+2.07%
0.00
+0.00%
0.00
Ordinary Shares Number
0.00
+87.40%
0.00
+2.07%
0.00
+0.00%
0.00
Additional Paid In Capital
21.88
+109.90%
10.42
0.00
—
Retained Earnings
-29.10
-157.55%
-11.30
-4.91%
-10.77
-83.26%
-5.88
Gains Losses Not Affecting Retained Earnings
0.41
+0.73%
0.41
-39.11%
0.68
+1138.46%
-0.07
Other Equity Adjustments
0.41
+0.73%
0.41
-39.11%
0.68
+1138.46%
-0.07
Total Equity Gross Minority Interest
-6.79
-1386.43%
-0.46
+95.47%
-10.09
-69.79%
-5.94
Total Capitalization
-6.79
-1386.43%
-0.46
+94.46%
-8.25
-58.94%
-5.19
Working Capital
-8.03
-304.12%
3.93
+194.16%
-4.18
—
Invested Capital
0.44
-17.05%
0.53
+106.54%
-8.08
-55.57%
-5.19
Total Debt
7.46
+657.06%
0.98
-51.00%
2.01
+168.36%
0.75
Net Debt
6.68
—
2.01
+168.36%
0.75
Capital Lease Obligations
0.23
0.00
—
—
Net Tangible Assets
-6.79
-1386.43%
-0.46
+95.47%
-10.09
-69.88%
-5.94
Tangible Book Value
-6.79
-1386.43%
-0.46
+95.47%
-10.09
-69.88%
-5.94
Current Notes Payable
0.57
+210.81%
0.18
—
—
Derivative Product Liabilities
0.14
-2.82%
0.14
0.00
—
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-9.68
-25.33%
-7.72
-240.91%
-2.27
-5.35%
-2.15
Cash Flow From Continuing Operating Activities
-9.68
-25.33%
-7.72
-240.91%
-2.27
-5.35%
-2.15
Net Income From Continuing Operations
-17.80
-3227.48%
-0.54
+89.05%
-4.89
-33.63%
-3.66
Depreciation Amortization Depletion
0.46
0.00
—
—
Depreciation
0.01
0.00
—
—
Amortization Cash Flow
0.45
0.00
—
—
Depreciation And Amortization
0.46
0.00
—
—
Amortization Of Intangibles
0.45
0.00
—
—
Other Non Cash Items
2.97
+199.60%
0.99
+274.34%
0.27
—
Stock Based Compensation
1.63
+720.10%
0.20
0.00
—
Provisionand Write Offof Assets
0.00
+100.00%
-0.24
-172.51%
0.33
—
Operating Gains Losses
3.20
+156.91%
-5.62
-493.63%
1.43
+859.06%
0.15
Gain Loss On Investment Securities
2.48
+144.32%
-5.60
-491.74%
1.43
+859.06%
0.15
Net Foreign Currency Exchange Gain Loss
0.01
+133.33%
-0.04
0.00
—
Change In Working Capital
-0.14
+94.36%
-2.52
-522.15%
0.60
-56.08%
1.36
Change In Prepaid Assets
-2.27
-129.60%
-0.99
0.00
—
Change In Payables And Accrued Expense
2.25
+247.29%
-1.53
-354.74%
0.60
-55.71%
1.36
Change In Accrued Expense
1.03
+158.99%
-1.75
-390.52%
0.60
-55.71%
1.36
Change In Payable
1.23
+469.77%
0.21
—
—
Change In Account Payable
1.23
+469.77%
0.21
0.00
—
Change In Other Working Capital
—
—
0.33
—
Change In Other Current Assets
0.00
-100.00%
0.01
+200.00%
-0.01
0.00
Change In Other Current Liabilities
-0.12
0.00
—
—
Investing Cash Flow
-0.04
-105.93%
0.72
+496.17%
-0.18
0.00
Cash Flow From Continuing Investing Activities
-0.04
-105.93%
0.72
+496.17%
-0.18
0.00
Net PPE Purchase And Sale
-0.05
0.00
—
—
Purchase Of PPE
-0.05
0.00
—
—
Capital Expenditure
-0.05
—
—
—
Net Investment Purchase And Sale
0.01
-98.39%
0.50
+235.81%
0.15
0.00
Purchase Of Investment
-0.49
0.00
—
—
Sale Of Investment
0.50
+0.20%
0.50
+235.81%
0.15
0.00
Net Other Investing Changes
—
0.23
+168.88%
-0.33
—
Financing Cash Flow
6.07
-44.49%
10.93
+346.45%
2.45
+28.98%
1.90
Cash Flow From Continuing Financing Activities
6.07
-44.49%
10.93
+346.45%
2.45
+28.98%
1.90
Net Issuance Payments Of Debt
2.45
+7.17%
2.29
+106.50%
1.11
+60.90%
0.69
Issuance Of Debt
3.23
+41.12%
2.29
+106.50%
1.11
+60.90%
0.69
Repayment Of Debt
-0.78
0.00
—
—
Long Term Debt Issuance
—
2.29
+106.50%
1.11
+60.90%
0.69
Net Long Term Debt Issuance
—
2.29
+106.50%
1.11
+60.90%
0.69
Short Term Debt Issuance
3.23
+41.12%
2.29
—
—
Short Term Debt Payments
-0.78
0.00
—
—
Net Short Term Debt Issuance
2.45
+7.17%
2.29
—
—
Net Common Stock Issuance
3.33
0.00
-100.00%
1.34
+10.83%
1.21
Proceeds From Stock Option Exercised
0.29
0.00
—
—
Net Other Financing Charges
—
8.64
—
—
Changes In Cash
-3.66
-193.10%
3.93
+393000.00%
-0.00
+99.60%
-0.25
Effect Of Exchange Rate Changes
-0.02
-105.35%
0.30
+29800.00%
0.00
+0.00%
0.00
Beginning Cash Position
4.23
0.00
0.00
-100.00%
0.25
End Cash Position
0.55
-86.90%
4.23
0.00
0.00
Free Cash Flow
-9.73
-25.99%
-7.72
-240.91%
-2.27
-5.35%
-2.15
Interest Paid Supplemental Data
0.08
-35.48%
0.12
0.00
—
Common Stock Issuance
3.33
0.00
-100.00%
1.34
+10.83%
1.21
Issuance Of Capital Stock
3.33
0.00
-100.00%
1.34
+10.83%
1.21
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category